A Deep Dive into the Antibody SGN-70 This therapeutic antibody represents a exciting treatment in the field of oncology, specifically targeting the CD22 protein expressed on malignant blood cells. Developed by SGN, https://liviapuwu915264.blognody.com/50095721/text